4
Changes in Ownership
ClearPoint Neuro, Inc. Filed Acc 0001193125-26-292932
CEO and President sold 20,000 shares at $19.38 ($387,600)
- CEO and President acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BURNETT JOSEPH CEO and President | 2026-06-29 | Option exercise 10b5-1 | +20,000 | $2.50 | $50,000 | 136,842 | D: show line 1 in the form |
| BURNETT JOSEPH CEO and President | 2026-06-29 | Sale 10b5-1 | −20,000 | $19.38 | $387,600 | 116,842 | D: show line 2 in the form |
| Open-market sales · 20,000 sh · avg $19.38 · $387,600 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| BURNETT JOSEPH CEO and President | 2026-06-29 | Option exercise · Stock Options (right to buy) 10b5-1 | −20,000 | 250,000 | D: show line 3 in the form |
Loading xslF345X06/ownership.xml…